Estrogen Receptor Hormone Agonists Limit Trauma Hemorrhage Shock-Induced Gut and Lung Injury in Rats by Doucet, Danielle et al.
Estrogen Receptor Hormone Agonists Limit Trauma
Hemorrhage Shock-Induced Gut and Lung Injury in Rats
Danielle Doucet, Chirag Badami, David Palange, R. Paul Bonitz, Qi Lu, Da-Zhong Xu, Kolenkode B.
Kannan, Iriana Colorado, Rena Feinman, Edwin A. Deitch*
Department of Surgery, University of Medicine & Dentistry of New Jersey (UMDNJ)-New Jersey Medical School, Newark, New Jersey, United States of America
Abstract
Background: Acute lung injury (ALI) and the development of the multiple organ dysfunction syndrome (MODS) is a major
cause of death in trauma patients. Earlier studies in trauma hemorrhagic shock (T/HS) have documented that splanchnic
ischemia leading to gut inflammation and loss of barrier function is an initial triggering event that leads to gut-induced
ARDS and MODS. Since sex hormones have been shown to modulate the response to T/HS and proestrous (PE) females are
more resistant to T/HS-induced gut and distant organ injury, the goal of our study was to determine the contribution of
estrogen receptor (ER)a and ERb in modulating the protective response of female rats to T/HS-induced gut and lung injury.
Methods/Principal Findings: The incidence of gut and lung injury was assessed in PE and ovariectomized (OVX) female rats
subjected to T/HS or trauma sham shock (T/SS) as well as OVX rats that were administered estradiol (E2) or agonists for ERa
or ERb immediately prior to resuscitation. Marked gut and lung injury was observed in OVX rats subjected to T/HS as
compared to PE rats or E2-treated OVX rats subjected to T/HS. Both ERa and ERb agonists were equally effective in limiting
T/HS-induced morphologic villous injury and bacterial translocation, whereas the ERb agonist was more effective than the
ERa agonist in limiting T/HS-induced lung injury as determined by histology, Evan’s blue lung permeability, bronchoalevolar
fluid/plasma protein ratio and myeloperoxidase levels. Similarly, treatment with either E2 or the ERb agonist attenuated the
induction of the intestinal iNOS response in OVX rats subjected to T/HS whereas the ERa agonist was only partially
protective.
Conclusions/Significance: Our study demonstrates that estrogen attenuates T/HS-induced gut and lung injury and that its
protective effects are mediated by the activation of ERa,E R b or both receptors.
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Introduction
Trauma is the leading cause of death in people under the age of
40 and development of the multiple organ dysfunction syndrome
(MODS) is a leading cause of death in trauma patients surviving
the initial 72 hour injury period as well as in other intensive care
unit patient populations [1]. Although somewhat controversial, the
majority of the clinical [2–4] and experimental [2,5] evidence
emerging over the last decade suggest that the response to injury,
shock and sepsis may differ between males and females, with
females being more resistant to the adverse consequences of
trauma and sepsis than males. Thus, understanding the mecha-
nisms by which trauma-hemorrhagic shock (T/HS) leads to
MODS, as well as the role of sex hormones in modulating this
response, is of major potential health importance.
In previous work, utilizing male rats, non-human primates and
mini-pigs, we found that T/HS-induced acute lung injury, as well
as neutrophil activation, RBC dysfunction, bone marrow suppres-
sion and endothelial cell injury and dysfunction were related to gut
injury and the release of gut-derived factors into the mesenteric
lymphatics rather than the portal vein [6–8]. Based on the
pioneering work from Dr Chaudry’s laboratory showing that sex
hormones are important modulators of the response to T/HS
[5,9], we carried out subsequent studies investigating the role of
sex hormones in the susceptibility and resistance to T/HS-induced
gut injury and gut-induced MODS. The results of this work
indicated that female rats were more resistant to T/HS-induced
gut injury and did not produce biologically-active mesenteric
lymph [10,11]. Furthermore, we found that sex hormone-related
gut protection was associated with abrogation of T/HS-induced
lung injury [12], neutrophil activation [11], RBC dysfunction [13]
and bone marrow suppression [14,15].
In the present study, we hypothesized that estrogen protected
against T/HS-induced gut injury, at least in part, by limiting
enterocyte iNOS production which in turn prevented gut-induced
lung injury. The rationale for studying the effects of estrogen as
well as selective estrogen receptor (ER)a and b agonists on
enterocyte iNOS induction in T/HS-induced gut injury is based
on three major lines of evidence. First, there is a large body of
evidence documenting that increased iNOS activity is involved in
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injury in a number of model systems [16,17]. Secondly, our
previous observations documented a direct correlation between
the magnitude of nitric oxide production and gut injury in both
hormonally intact and hormonally-modulated male and female
rats subjected to T/HS [12,18]. Lastly, there is increasing
experimental evidence that estrogen’s protective effects, in models
of T/HS and sepsis, are occuring via a non-genomic mechanism
involving the activation of specific ERs and that their cellular
distribution varies from tissue-to-tissue [19–21]. Our findings
demonstrate that the adminstration of estradiol (E2) or the ERb
agonist, and to a lesser degree the ERa agonist, ameliorated T/
HS-induced gut and lung injury in ovarectomized (OVX) female
rats. Furthermore, treatment with E2 or the ERb agonist blunted
the T/HS-induced ileal iNOS response in OVX female rats.
These results further validate the concept that estrogen is a key sex




The first goal of this study was to examine the role played by the
individual estrogen receptors in the protection experienced in
female rats during hemorrhagic shock as well as its relationship to
multiple-organ failure. In this experiment, both proestrus female
(PE) rats and OVX rats were subjected to either laparotomy and
controlled hemorrhagic shock (T/HS, 35 mm Hg for 90 minutes)
or laparotomy plus sham-shock (T/SS). OVX animals were
randomized into 4 groups 1) receiving no drug and acting as the
negative control, 2) receiving ERa agonist propyl pyrazole triol
(PPT, 5 mg/kg BW), 3) receiving ERb agonist diarylpropionitrile
(DPN, 5 mg/kg BW) or 4) receiving 17b-estradiol (E2, 50 mg/kg
BW). Dosing for all drugs used was obtained from previously
published studies [22]. Both ER agonists were obtained from
Tocris Cookson Incorporated (Ellisville MO) and PPT has been
shown to be a sub-type specific ERa agonist with 410-fold
specificity for ERa over ERb, while DPN has a 70-fold specificity
for ER b over ERa [23]. The EC50 for PPT is approximately
200 pM and for DPN it is 0.85 nm. Thus, based on the EC50 of
the ER agonists, the dose chosen would be about 50–100 times this
EC50 and thus should be at high enough doses to saturate their
respective ER but not so high as to lose specificity. All drugs were
dissolved in DMSO (Sigma-Aldrich) and were administered
immediately prior to resuscitation during the shock or sham-shock
period via intraperitoneal (IP) injection. At 3 hours after the shock
or sham-shock period, the animals were sacrificed, following which
organs and blood were harvested for study. The small intestine was
the first organ system examined. Gut injury was measured using
histologic evaluation of the percentage of villi injured. Gut
permeability was measured by assessing the mesenteric lymph
nodes for bacterial translocation. Lung permeability and pulmo-
nary leukosequestration were measured as markers of organ
dysfunction. Lung permeability was quantified by calculating
percentage of Evan’s Blue dye (EBD) present in the broncho-
alveolar lavage fluid (BALF) when compared to the plasma. EBD
has been shown to be a good indicator of protein leak within the
lung as it binds to albumin. The protein content of the BALF and
plasma were measured and the amount of BALF protein was used
as a second marker of pulmonary permeability. Pulmonary
leukosequestration was utilized as a marker of lung injury by
quantifying pulmonary myeloperoxidase (MPO).
Since increased iNOS activity and the production of nitric oxide
has been implicated in the pathogenesis of T/HS-induced gut
injury [16,17], the second goal was to investigate the potential
modulatory effects of individual estrogen receptors on T/HS-
induced iNOS expression within the intestine.
Animals
Female and OVX female Sprague-Dawley rats (Charles River),
weighing 300 to 375 g, were used after a minimum acclimatization
period of 5 days. OVX animals were allowed at least 14 days after
ovarectomy prior to use. All animals were housed under barrier-
sustained conditions and kept at 25uC with 12-hour light/dark
cycles. The rats had free access to water and chow (Teklan 22/5
Rodent Diet W-8640, Harlan Teklad). All rats were maintained in
accordance with the recommendations of the Guide for the Care
and Use of Laboratory Animals. The New Jersey Medical School
Animal Care Committee approved all animal protocols.
Surgical Procedure
Rats were anesthetized with IP sodium pentobarbital (50 mg/
kg). Using aseptic techniques, the femoral artery and internal
jugular vein were isolated and cannulated with polyethylene (PE-
50) tubing and 50-gauge silicone catheter containing 0.1 mL
heparinized saline (10 units/mL), respectively. Both catheters
remained in place for the duration of the experiment. Next, a 3-cm
midline laparotomy (trauma) was performed with exposure of the
intestine for 15 minutes, followed by closure with a running 4–0
silk suture. Continuous blood pressure monitoring was achieved
via the femoral artery catheter (BP-2 Digital Blood Pressure
Monitor, Columbus Instruments). Blood was then withdrawn from
the internal jugular vein catheter. The mean arterial pressure was
reduced to 35 mm Hg and maintained at this level for 90 minutes
by withdrawing or re-infusing shed blood as needed. The animals
temperature was maintained during the shock period at approx-
imately 37uC by using an electric heating pad under the surgical
platform. At the end of the shock period, animals were resuscitated
by re-infusing all of the shed blood, restoring the blood pressure
back to pre-shock levels. All treatment drugs (17b estradiol, DPN
or PPT] were administered via intra-peritoneal injection just prior
to resuscitation with shed blood. The T/SS rats were anesthetized,
their vessels cannulated, and underwent a laparotomy, but no
blood was withdrawn or infused. All animals remained anesthe-
tized throughout the duration of the experiment.
Determination of Menstrual Stage
Female rats were periodically screened via vaginal swabbing to
determine the stage of the estrus cycle as described by Baker et al
[24]. All the non-ovariectomized rats were studied only during the
PE stage of the estrus cycle.
Bacterial Translocation
The mesenteric lymph node (MLN) complex was harvested and
the level of translocating bacterial quantified as previously
described [25]. Briefly, using sterile technique, the MLN complex
was harvested, weighed and homogenized in 0.5 ml of sterile
saline. Aliquots were plated onto both blood and MacConkey agar
plates. These plates were examined at 24 hours of aerobic
incubation at 37uC. The colonies were counted on the plates
and recorded as bacteria per gram of tissue.
Histological Analysis of Gut
After sacrifice, a segment of the terminal ileum was excised and
fixed in 10% buffered formalin. After processing, semi-thin (2–
4 mm) sections were cut, stained with H&E and examined using
light microscopy at 1006magnification. In order to deem a villus
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ranged from submucosal edema at the villous tip to frank necrosis
of the villi. A total of five random fields from each animal were
examined, and the percentage of villous damage for each animal
was determined. All results are expressed as the percentage of villi
injured per high-power field. All histologic evaluations were
performed in a blinded fashion.
Lung Permeability
Prior to sacrifice, a reference sample was obtained for protein
determination. Immediately following collection, 1 mL of EBD
was injected via the internal jugular catheter. After 5 minutes, a
1 mL blood sample was withdrawn from the femoral arterial
catheter, centrifuged and serial dilutions of the plasma were made
to generate an EBD standard curve. After 20 minutes, the lungs
were excised and bronchoalveolar lavage (BAL) was performed.
The lungs were instilled with 5 mL of phosphate-buffered saline
(PBS), rinsed 3 times with PBS and the BALF was collected and
centrifuged to remove any cells or debris. EBD in the BALF was
measured spectrophotometrically at 620 nm and the concentra-
tion of EBD in the BALF was determined by the standard curve.
The percentage of EBD in the BALF relative to EBD in the
plasma was determined. As a second marker for lung permeability,
the BALF/plasma protein ratio was also measured using a
refractometer as previously described [26].
Myeloperoxidase Assay
MPO activity was assessed in lung tissue as previously described
[26] and expressed as activity per gram of lung tissue, with 1 unit
of MPO activity being the amount of enzyme that will reduce
1 mmol of peroxide per minute.
Ileal iNOS Immunohistochemistry
Paraffin blocks containing lung tissue was cut in 5 mm thick
sections and iNOS positive cells were observed by immunoper-
oxidase staining. Lung sections were stained with rabbit anti-iNOS
antibody (Santa Cruz Biotechnology) or with control solutions.
Controls included buffer alone or nonspecific purified rabbit IgG.
Endogenous peroxidase activity was quenched though incubation
with 3% peroxide and specific iNOS labeling was detected
following incubation with biotinylated anti-rat IgG antibody and
avidin-biotin peroxidase complex ABC Kit (Santa Cruz Biotech-
nology). The slides were then counterstained with hematoxylin
(Sigma-Aldrich) and the number of iNOS positive cells was
quantified per 100 villi counted. To verify iNOS specificity, several
sections were incubated with primary antibody without secondary
antibody or secondary antibody without primary antibody.
Statistics
Bacterial Translocation data was analyzed using x
2 analysis
with Fisher exact test. All other data was analyzed using ANOVA
with the Tukey-Kramer multiple comparison test. Data is
expressed as mean 6 SD. A P value of less than 0.05 was
considered significant.
Results
As previously reported [18], T/HS caused more gut injury in
OVX female rats as compared to PE rats (Figure 1A). The
administration of E2 as well the ERa (PPT) and ERb (DPN)
agonists to the OVX female rats at the beginning of reperfusion
markedly reduced T/HS-induced villous injury. While all of the
T/HS groups did show some morphologic evidence of gut injury
when compared to their T/SS counterparts (Figure 1A), only the
OVX T/HS group demonstrated bacterial translocation to the
MLN complex (2.7610
3 and 2.5610
3 bacteria/gram of tissue
aerobic and enteric respectively) (Figure 1B). Thus, these results
suggest that E2 and both ER agonists were able to limit T/HS-
induced morphologic gut injury and prevent bacterial transloca-
tion.
Our earlier studies [18] demonstrated that PE female rats did
not develop increased lung permeability after T/HS. As an
extension of this observation, we tested the effects of E2 and the
ER agonists on T/HS-induced lung permeability. The adminis-
tration of E2 or the ERb agonist, DPN, fully prevented an increase
in T/HS-induced lung permeability (Figure 2A) whereas the ERa
agonist, PPT, was partially protective as compared to their
untreated OVX counterparts subjected to T/HS. Similarly,
treatment with E2 or PPT, the ERb agonist, reduced the
BALF/plasma protein ratio, a marker for lung permeability
(Figure 2B), as well as MPO levels (Figure 2C) in OVX rats
subjected to T/HS. DPN, the ERa agonist, was not as effective as
Figure 1. Estradiol and both estrogen receptor agonists ERa
and ERb are protective against T/HS induced gut injury. A) The
extent of villus injury 3 hours after T/HS was reduced back to the levels
observed in the PE females by all three estrogen-based therapies. A
minimum of 200 villi per animal was counted with 6–8 animals per
group. *p,0.001 vs all other T/HS groups, #p,0.05 vs all T/HS groups.
B) The incidence of bacterial translocation was increased only in the
OVX group subjected to T/HS. *p,0.01 vs all other groups with 6–8
animals per group.
doi:10.1371/journal.pone.0009421.g001
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ERb is more effective in limiting T/HS-induced lung injury and
neutrophil sequestration than ERa.
Since increased iNOS activation has been implicated in the
pathogenesis of gut injury after ischemia-reperfusion insults
[16,17], we tested the hypothesis that iNOS would be increased
in the enterocytes of OVX but not hormonally intact (PE) female
rats after T/HS and that this increased enterocyte iNOS response
would be abrogated by the administration of E2. As shown in
Figure 3A and 3B, the number of enterocyte iNOS positive cells
was increased to a much greater degree in the OVX female rats
than the hormonally intact female rats after T/HS. The
administration of either E2 or the ERb agonist completely
abrogated the effect of ovariectomy on T/HS-induced enterocyte
iNOS expression while the ERa agonist was partially protective.
Discussion
The biology of estrogen has been extensively studied for decades
due to its important reproductive, cardiovascular and other effects.
Initially, estrogen was thought to work through a genomic
mechanism, where over a period of hours to days, it induces gene
transcription and subsequent protein synthesis. However, it now
appears that estrogens can also exert their physiologic effects via
Figure 2. Estradiol and ERb are more effective than ERa in
conferring protection against T/HS induced lung injury. A) T/HS-
induced lung injury, as represented by the percentage of EBD leak
within the BALF or B) by the BALF/plasma protein ratio, was increased
in the ovariectomized rats and reduced by the administration of
estradiol of the estrogen receptor agonists. Data expressed as mean 6
SD with 6–8 rats per group. *p,0.01 vs all other groups except the ERa
T/HS group. #p,0.01 vs ERa T/SS group. C) T/HS increased the degree
of lung neutrophil sequestration, as reflected in MPO levels, in the OVX
rats and this was abrogated by the administration of E2 and the ERb but
not the ERa agonist. *p,0.05 vs all other groups.
doi:10.1371/journal.pone.0009421.g002
Figure 3. iNOS response is abrogated by both E2 and ERb. A)
The number of iNOS positive enterocytes was increased in all of the T/
HS groups but was highest in the OVX rats and the OVX rats receiving
the ERa agonist. Data expressed as mean 6 SD with a minimum of 100
villi counted per animal with 6–8 animals per group. * p,0.01 vs all
other groups, **p,0.01 vs all other groups, and #p,0.05 vs T/HS
groups. B) Representative immunohistochemistry micrographs showing
iNOS staining of enterocytes.
doi:10.1371/journal.pone.0009421.g003
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binding estrogen receptors and activating signaling systems within
the cytoplasm [19]. Our observation that the beneficial effects of
E2 administration or the administration of the ER agonists on gut
and lung function were rapidly observed is consistent with previous
studies on the immune system [27,28] and RBC function [28] as
well as organ function [29,30] suggesting that the beneficial effects
of the ER agonists are operating primarily through a non-genomic
pathway. Furthermore, because the density of ERa and ERb
varies between organs and among cell populations, these
differences could translate into differences in the response to
specific estrogen agonists at the tissue and/or cellular levels [20].
For example, similar to our lung results, earlier work from the
laboratory of Dr Chaudry has shown that tissues with higher
densities of ERb than ERa, such as the lung, are better protected
from T/HS-induced injury by ERb than ERa agonists [30].
Likewise, this same group has documented that ERa is more
important than ERb in mediating the immuno-protective effects of
estrogen on T cells and splenic macrophages as well as liver injury
in rats subjected to trauma-hemorrhage [20,27]. The fact that the
intestine contains both ERa and ERb may help explain why both
ER agonists limited T/HS-induced intestinal morphologic injury
and bacterial translocation to a similar extent as E2 in the current
study.
It has been well documented that splanchnic blood flow
decreases out of proportion to the overall decrease in cardiac
output in shock states and consequently that the gut is particularly
susceptible to ischemia-reperfusion injuries [31]. Based on an
increasing body of information, it also seems that the generation of
high levels of nitric oxide by iNOS during gut ischemia is involved
in the pathogenesis of gut injury [16,17,32]. Thus, we tested the
concept that T/HS-induced gut injury is related to the
combination of the production of excessive levels of iNOS-derived
nitric oxide as well as the generation of reactive oxidants and that
E2 would limit T/HS-gut and hence gut-induced lung injury, at
least in part, by limiting enterocyte iNOS induction. Thus, our
observation that hormonally-intact female rats subjected to T/HS
had less gut injury and limited induction of enterocyte iNOS as
compared to OVX rats supports this concept as does the fact that
E2 administration abrogated both the magnitude of gut injury and
intestinal iNOS response in OVX rats subjected to T/HS.
Furthermore, this observation that E2 limited enterocyte iNOS
induction after T/HS is supported by previous studies indicating
that intestinal enterocytes contain functional estrogen receptors
[33,34] and that part of estrogen’s protective effect on the
cardiovascular system occurs via its ability to limit iNOS induction
[35,36]. This notion that increased iNOS activity is a key factor
contributing to gut injury and loss of barrier function after T/HS
expands upon studies showing that gut injury is greatly reduced in
male as well as female iNOS knockout mice subjected to superior
mesenteric artery occlusion as compared to their wild-type
littermates [32]. Additionally, we and others have documented
that nitric oxide directly impairs intestinal barrier function [37,38]
and that LPS-induced enterocyte-derived nitric oxide induces
intestinal monolayer permeability in an autocrine fashion [39].
This observation that enterocyte iNOS-generated nitric oxide can
promote enterocyte injury in an autocrine fashion highlights the
concept that enterocytes can be targets as well as producers of
nitric oxide. Our results investigating the ability of E2 and specific
ER agonists to directly and specifically limit T/HS-induced
enterocyte iNOS induction extends our previous work document-
ing a gender difference in the plasma nitric oxide and total ileal
iNOS responses to T/HS where PE females were found to have a
blunted response as compared to males [12,18]. That is, to our
knowledge, the current work shows for the first time that E2 can
specifically limit T/HS-induced enterocyte iNOS induction and
that this protective effect is primarily being mediated through b
estrogen receptor signaling. However, one limitation of this
conclusion is that immunohistochemistry is only semi-quantitative
as compared to Western blotting analysis. On the other hand,
immunohistochemistry does have the advantage that it is specific
and can be used to clearly document that iNOS induction was
occurring in the enterocytes as opposed to other cells.
Although both ERa and ERb agonists limited morphologic gut
injury and bacterial translocation, the observation that enterocyte
iNOS induction after T/HS in the ovariectomized rats was
abrogated to a greater extent by the ERb than the ERa agonist
raises an important issue. That is, this observation suggests that the
mechanism by which the ERa agonist limited gut injury must
involve protective pathways or cell populations independent of its
ability to limit the enterocyte iNOS response. One possible
explanation is that a significant portion of the ERa agonist’s
protective effect is being mediated through non-enterocyte cell
populations, such as endothelial and immune cells. This possibility
is consistent with the fact that both the endothelium [40] and
immune cells [27] are more responsive to ERa than ERb agonists
and the intestinal blood flow is better preserved [41,42] in female
than male rats after T/HS. Additionally, ERa agonists have been
shown to limit T/HS-induced immune cell activation better than
ERb agonists [27]. Since gut injury after T/HS is multifaceted and
involves changes in microcirculatory blood flow, an intestinal
inflammatory response as well as enterocyte apoptosis and injury,
it is possible that estrogen’s protective effects on different
components of this process may be transduced via different
estrogen receptors. Clearly, further work is needed to sort out this
question. In this context, it is important to stress that one limitation
of this study was the fact that this was purely a pharmacologic
study and that only one dose of each drug was used. Specifically,
although the ER agonists are proposed to be highly selective and
the doses used in the current study were supported by previous
studies and the pharmacology of the agents [22,23], one can never
exclude the fact that any drug may have unknown target effects,
which can confound data interpretation. Consequently, it would
be important to carry out genetic-based studies to complement the
pharmacologic work reported here. For example, siRNA or
antisense knockdown approaches as well as the use of ERa and/or
ERb knockout mice could be used to validate as well as extend this
work. To date, the effects of major trauma or hemorrhagic shock
have not been tested in ERa or ERb knockout mice.
An additional important observation of potential clinical
relevance is that E2 as well as the ER agonists were effective
when used in a post-treatment regimen and administered at the
end of the shock period at the time of fluid resuscitation. It is
important to note that a limitation of ovariectomy in investigating
the role of estrogen as a protective factor is that ovariectomy
causes significant reductions in progesterone, prolactin and DHEA
in addition to estrogen [43]. Although estrogen is not the only sex-
related hormone altered by ovariectomy, our results showing that
the administration of E2 as well as the ER agonists were sufficient
in limiting gut and lung injury further validates the notion that
estrogen is the key sex hormone responsible for abrogating gut and
lung injury as well as enterocyte iNOS induction after T/HS in
female rats.
In the aggregate, although the current as well as other
preclinical studies generally indicate that estrogen exerts a
protective effect on various organ and cellular systems in shock-
trauma models, caution must be exercised in directly applying
these results to the clinical arena. That is, clinical studies of major
ERa and ERb Limit Injury
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populations are not as clear in showing clinical benefit for females,
especially when mortality is used as the primary outcome measure
[2,3,44]. There are several potential explanations for this fact,
including the limitations of preclinical trauma-shock models, such
as the fact that all of the animals are healthy and have no pre-exist
illnesses or confounding social issues such as alcohol ingestion
[44,45]. Additionally, the immuno-inflammatory response of
rodents differ to some degree from those of humans [45] as well
as the fact that sex hormone levels rapidly change over time in
trauma and other patient groups [46,47] and these patients
frequently develop secondary complications, such as sepsis and
other second insults during their hospital course that lead to
adverse clinical outcomes. Nonetheless, the current study supports
the theory that the magnitude of acute gut and lung injury after
T/HS are limited by estrogens and that this protection is mediated
at least in part through selective estrogen-receptors acting in a
rapid non-genomic fashion.
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